Labeled ALPHA4BETA2 ligands and methods therefor
Patent
·
OSTI ID:1082891
Contemplated compositions and methods are employed to bind in vitro and in vivo to an .alpha.4.beta.2 nicotinic acetylcholine receptor in a highly selective manner. Where such compounds are labeled, compositions and methods employing such compounds can be used for PET and SPECT analysis. Alternatively, and/or additionally contemplated compounds can be used as antagonists, partial agonists or agonists in the treatment of diseases or conditions associated with .alpha.4.beta..beta.2 dysfunction.
- Research Organization:
- DOESC (USDOE Office of Science (SC) (United States))
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-03ER63598
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,378,109
- Application Number:
- 11/721,145
- OSTI ID:
- 1082891
- Country of Publication:
- United States
- Language:
- English
Similar Records
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: ( sup 3 H)nicotine as an agonist photoaffinity label
Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain - In vitro and ex vivo evidence
Journal Article
·
Thu Nov 15 00:00:00 EST 2012
· Toxicology and Applied Pharmacology
·
OSTI ID:1082891
Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: ( sup 3 H)nicotine as an agonist photoaffinity label
Journal Article
·
Tue Jul 16 00:00:00 EDT 1991
· Biochemistry; (United States)
·
OSTI ID:1082891
Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain - In vitro and ex vivo evidence
Journal Article
·
Thu Oct 15 00:00:00 EDT 2009
· Toxicology and Applied Pharmacology
·
OSTI ID:1082891
+2 more